Trials / Completed
CompletedNCT03695432
Probiotic and Influenza Vaccination to Reducing Influenza-like Illness Incident in Elderly
Role of Probiotic and Influenza Vaccination on Immune Response Enchancement and Influenza-Like Illness Incidence Reduction in Elderly
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 910 (actual)
- Sponsor
- Indonesia University · Academic / Other
- Sex
- All
- Age
- 60 Years – 90 Years
- Healthy volunteers
- Accepted
Summary
To asses the effect of the probiotic and influenza vaccination alone and combination on enhancing immune response to influenza-like illness (ILI) and reducing ILI incidence in the elderly
Detailed description
To see percetange of subjects seroconvertion and seroprotection before and after intervention in the elderly (\>60 years), and monitored for 6 months.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Flubio | Flubio (A/California/7/2009, A/Texas/50/2012 and B/Massachusetts/2/2012) Vaccine 0,5 ml for every subjects The vaccine will be given intramuscularly |
| DIETARY_SUPPLEMENT | Lacidofil | Lacidofil (Lactobacillus acidophilus Rossel-52 and Lactobacillus rhamnosus Rosell-11 with maltodextrin 211 mg, magnesium stearat 8 mg and ascorbic acid 1 mg) antibiotic The antibiotic will be given 2 times each day for 6 months |
| OTHER | Placebo Vaccine | Nacl 0,9% 0,5 ml The placebo vaccine will be given intramuscularly |
| OTHER | Placebo probiotic | Capsul |
Timeline
- Start date
- 2014-10-01
- Primary completion
- 2015-04-01
- Completion
- 2016-07-01
- First posted
- 2018-10-04
- Last updated
- 2018-10-05
Locations
1 site across 1 country: Indonesia
Source: ClinicalTrials.gov record NCT03695432. Inclusion in this directory is not an endorsement.